METROPOLITAN HOSPITAL
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $1.2M
- Transactions
- 595
- Companies
- 40
- Average per transaction
- $2,058
Who reported the payments
| Genentech, Inc. | $217,193 |
| AstraZeneca | $200,949 |
| Novartis | $147,805 |
| Penumbra, Inc. | $102,443 |
| Cardiovascular Systems Inc. | $89,320 |
| Bard Peripheral Vascular, Inc. | $68,278 |
| Microvention, Inc. | $66,800 |
| Stryker | $57,236 |
| ZOLL Respicardia, Inc. | $37,450 |
| Biotronik Inc. | $37,069 |
| Boston Scientific | $25,808 |
| Genentech USA, Inc. | $18,800 |
| Bayer | $17,847 |
| EKOS Corporation | $17,190 |
| Pfizer | $14,030 |
| Regeneron Healthcare Solutions, Inc. | $10,000 |
| Chiesi USA, Inc. | $10,000 |
| Johnson & Johnson | $9,963 |
| Abbott | $7,602 |
| Edwards Lifesciences | $7,500 |
| Novo Nordisk | $6,500 |
| Medline Industries LP | $5,181 |
| Siemens Medical Solutions USA, Inc. | $5,047 |
| E.r. Squibb & Sons, L.L.C. | $5,000 |
| W. L. Gore & Associates, Inc. | $5,000 |
| Medical Device Business Services, Inc. | $4,500 |
| Merck | $2,930 |
| Teleflex LLC | $2,725 |
| Corcept Therapeutics | $2,500 |
| Boehringer Ingelheim | $2,500 |
| Portola Pharmaceuticals, LLC | $2,500 |
| Sanofi | $2,500 |
| Smith+Nephew | $2,500 |
| Amgen | $2,500 |
| Covidien LP | $2,000 |
| Sanofi-aventis U.S. LLC | $1,500 |
| Philips North America LLC | $1,500 |
| Alcresta Therapeutics, Inc. | $1,000 |
| Sterilmed, Inc. | $997 |
| Acerta Pharma LLC | $720 |